News & Analysis on Clinical Trial Services & Contract Research And Development
Domantis has announced an alliance with pharma giants Bristol-Myers Squibb to develop human Domain Antibody (dAb) products, a novel approach to address therapeutic targets involved in T-cell co-stimulation.
A dairy based vaccine could soon be on the horizon after researchers took a giant step in the development of a series of effective cancer-fighting vaccines that appear to be able to stop and reverse cancer growth.
Researchers believe that they have identified a drug target molecule that could be used to treat mental impairment in people with Down's syndrome paving the way for a treatment that could improve the quality of life for sufferers.
Stratagene announces a molecular diagnostics agreement, which aims to focus on the growing molecular diagnostics market for infectious diseases, currently worth $6.5 billion (€5.5 billion), expanding to $12 billion by 2010 driven biochip and...
The question as to why some cancers resist drugs could be answered by the discovery of new mechanisms, which delve deeper into how cancer cells evolve to become resistant to various chemotherapy drugs.